A series of new arylpiperazide derivatives of serotonin has been prepared and evaluated as 5-HT1D receptor agonists. Binding experiments at cloned human 5-HT1D alpha, 5-HT1D beta, and 5-HT1A receptors show that all the compounds are very potent and selective ligands for 5-HT1D receptor subtypes. Functional activity studies (contraction of the New Zealand white rabbit saphenous vein) demonstrate that most of the derivatives behave as full agonists. Among them, the aryl sulfonamide derivative 5q (pD2 = 8.33 compare to 5.75 for sumatriptan) was also identified as a very potent agonist in inhibiting the forskolin-mediated cyclase coupled to 5-HT1D beta receptors (EC50 = 0.52nM).
Synthesis and Serotonergic Activity of Arylpiperazide Derivatives of Serotonin: Potent Agonists for 5-HT1D Receptors.-A series of arylpiperazide derivatives ( ∼ =20 examples) such as (I) and (V) is prepared and evaluated as 5-HT1D receptor agonists. All title compounds are very potent and selective ligand for 5-HT1D receptor subtypes in binding experiments at cloned human 5-HT1Dα, 5-HT1Dβ, and 5-HT1A receptors. Functional activity studies show that most of the derivatives behave as full agonists. The sulfonamide ( Id) is identified as very potent agonist in inhibiting the forskolin-mediated cyclase coupled to 5-HT1Dβ receptors. -(PEREZ, M.; FOURRIER, C.; SIGOGNEAU, I.; PAUWELS, P. J.; PALMIER, C.; JOHN, G. W.; VALENTIN, J.-P.; HALAZY, S.; J. Med. Chem. 38 (1995) 18, 3602-3607; Lab. Cardiovasc. Dis. Div., Cent. Rech. Pierre Fabre, F-81106 Castres, Fr.; EN)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.